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dDivision of Breast Imaging, Department of Radiology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USAAbstractBackground: Previous studies of patients with invasive breast cancer examined, with mixed results, tumour location as a predictor of axillary
lymph node metastasis. This study assessed whether tumour location in relation to the nipple impacts the presence of axillary lymph node
metastasis at the time of diagnosis.
Methods: A retrospective review was undertaken of the medical records and available imaging of 285 patients diagnosed with invasive breast
cancer between January 2001 to June 2007 at Boston University Medical Center. The incidence of axillary lymph node metastasis was
correlated with tumour location in relation to the posterior nipple line to control for variation in breast size. Bivariate analysis identified
significant variables that were applied to a multiple logistic regression model.
Results: Axillary lymph node metastasis was not significantly associated with tumour proximity to the nipple. In the multivariate logistic
regression analysis, known prognostic factors for axillary metastasis, such as surgical size, lymphovascular invasion, and age of diagnosis,
were significant, whereas breast density, palpability, and histologic grade were no longer significant.
Conclusions: Our study found that there was no evidence that correlates intramammary tumour proximity to the nipple with the presence of
axillary lymph node metastasis at diagnosis. However, known prognostic factors, such as lymphovascular invasion, surgical size, and younger
age at diagnosis, are strong independent predictors for axillary lymph node involvement.Re´sume´Contexte: Des e´tudes ante´rieures, dont les re´sultats sont mitige´s, ont e´te´ effectue´es sur des patientes atteintes d’un cancer du sein invasif et
portaient pre´cise´ment sur l’emplacement de la tumeur en tant que pre´dicteur d’une me´tastase ganglionnaire axillaire. L’e´tude actuelle visait a`
e´valuer si la proximite´ de la tumeur par rapport au mamelon pouvait influencer la pre´sence de me´tastase ganglionnaire axillaire au moment du
diagnostique.
Me´thode: une e´tude re´trospective a e´te´ effectue´e et portait sur les dossiers me´dicaux et les examens d’imagerie disponibles de 285 patientes
atteintes d’un cancer du sein invasif de janvier 2001 a` juin 2007 au « Boston University Medical Center ». L’incidence de me´tastase
ganglionnaire axillaire a e´te´ mise en relation avec la localisation de la tumeur, selon la ligne mamelonaire poste´rieure, pour tenir compte de
la taille du sein. Une analyse bivarie´e a identifie´ des variables significatives qui on e´te´ applique´es a` un mode`le de re´gression logistique
multiple.
Re´sultats: Les me´tastases ganglionnaires axillaires n’e´taient pas significativement associe´es a` la proximite´ de la tumeur par rapport au
mamelon. A l’analyse, les facteurs pronostiques connus pour les me´tastases axillaires, comme le taille a` la chirurgie, l’envahissement
lymphovasculaire, et l’aˆge au diagnostique e´taient importants alors que la densite´ du sein, le grade histologique et la fait que la le´sion soit
palpable ne l’e´tait plus.
Conclusion: Notre e´tudemontrequ’il n’y apas d’e´videncede relation entre laproximite´ aumamelond’une tumeur inta-mammaire et lapre´sencede
me´tastases ganglionnaires axillaires au moment du diagnostique. Toutefois, les facteurs pronostiques connus, comme l’envahissement* Address for correspondence: Priscilla J. Slanetz, MD, MPH, FACR,
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important parameter in determining breast cancer staging
and treatment [1]. Specifically in women with small invasive
breast carcinomas (less than 1 cm in size), the detection of
axillary lymph node metastasis guides treatment regimens
[2]. In the last decade, numerous studies correlated certain
breast tumour characteristics, such as tumour size, histologic
grade, palpability, and lymphovascular invasion, with
a greater chance of axillary metastasis at the time of diag-
nosis [3e8]. In addition, many researchers have tried to
determine if intramammary location of the breast tumour
correlates to a higher rate of axillary metastasis and, there-
fore, a worse prognosis. Although some studies examined the
breast 2-dimensionally by comparing medial with lateral
locations, other studies tried to look at the breast 3-dimen-
sionally comparing anterior with posterior regions [9e12]. In
this retrospective analysis, we assessed tumour location by
combining the 2-dimensional and 3-dimensional views of the
breast by analysing tumour location on imaging relative to its
relationship to the nipple. Because deep lymphatic channels
of the breast anastomose at the subareolar plexus, which then
drain to the axilla, we proposed that tumours close to the
nipple should have a higher rate of axillary lymph node
metastasis at diagnosis [13].
Methods
This study was approved by the institutional review board
at Boston University Medical Center. Between January 2001
and June 2007, 604 women diagnosed with invasive breast
cancer were identified through a computerized database from
the Clinical Data Warehouse at Boston University Medical
Center. The database provided personal identifying infor-
mation, medical record number, demographic details, and
tumour stage. The information about clinical presentation
and course, family history of breast cancer in first-degree
relatives, diagnosis, histopathology, and radiologic studies
was available from hospital records.
Of the population of 604 with the qualifying diagnosis of
invasive cancer, 285 participants (47%) were eligible for the
study. Eligibility criteria included any female of any age or
ethnicity, histologically confirmed invasive breast cancer stage
T1 or higher, available surgical axillary staging data from
either sentinel lymph node biopsy or full axillary dissection,
available mammogram before cancer treatment, and axillary
staging before chemotherapy or radiation therapy. In addition,
eligibility required there to be a single breast primary. A total
of 319 patients (53%) were excluded from the study for the
following reasons: radiologic examinations unavailable (165),
axillary status unavailable (97), chemotherapy before axillarystaging (30), multifocal cancer (10), no surgery performed (7),
unavailable medical records (7), Paget disease (2), and radia-
tion before axillary staging (1).
The mammographic studies were performed by using
dedicated equipment (General Electric DMR,Milwaukee,WI;
LoRad MIV, Hologic, Bedford, MA; Hologic Selenia, Bed-
ford, MA). By using the cranial-caudal view of the breast, the
location of the tumour was demarcated by a board-certified
radiologist who specializes in breast imaging with film-
screen or digital hard copy images. The distance of the
lesion from the nipple was measured in its relation to the
posterior nipple line (from the surface of the nipple to the edge
of the pectoralis muscle). Two relationships to the posterior
nipple line were calculated by using a triangle drawn on the
breast. One relationship was calculated of where the lesion fell
parallel to the posterior nipple line, and the other relationship
was where the tumour fell radially oriented to the posterior
nipple line (Figure 1). These measurements allowed stan-
dardization, given the differences in breast size among
patients. On available ultrasound images, a measurement was
taken from the skin surface to themost superficial aspect of the
tumour to determine the distance from the skin. The ultrasound
studieswere performed by using 2 different systems (ATLHDI
or iU22 units; Philips, Amsterdam, The Netherlands), with
either a 12.5 MHz or 17 MHz linear probe.
Clinical data from the eligible 285 patients with stage T1
or higher breast cancer were collected retrospectively from
patient records. The clinical factors assessed were the
following: age at diagnosis, history of use of oral contra-
ceptives or hormone replacement therapy, palpability of
primary tumour, family history of breast cancer, prior history
of breast cancer, or a benign neoplasm. The radiologic
factors assessed were the following: density of the breast
(classified by using the 4 Breast Imaging Reporting and Data
System [BI-RADS] density categories) [14], and the distance
from skin on ultrasound. Data about location of tumour were
grouped into (1) breast quadrants (upper outer quadrant
[UOQ], upper inner quadrant [UIQ], lower outer quadrant
[LOQ], lower inner quadrant [LIQ]), periareolar (defined as
nipple and 1 cm from nipple); (2) breast regions (lateral,
medial, periareolar); and (3) relationship of tumour to the
posterior nipple line (Figures 1 and 2). The pathologic
factors evaluated were the following: tumour size (maximum
diameter of invasive component measured microscopically),
histologic type (based on the International Classification of
Diseases, Oncology Classification System), histologic grade
(by using the modified Scarff-Bloom-Richardson system),
lymphovascular invasion, tumour calcifications present,
estrogen/progesterone/Her2 immunohistochemical value,
and the number of positive axillary lymph nodes.
Figure 1. Relationship of breast tumour to the nipple was made by first
drawing the posterior nipple line (pnl) on the craniocaudal view of the
breast. Two relationships were calculated: (1) a/pnl: relationship of the
tumour along the pnl; and (2) c/pnl: relationship of the tumour radially
oriented to pnl. All measurements were performed in centimetres.
Figure 2. Right breast.
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metastasis) and each clinical variable were assessed by using
logistic regression. Candidate variables were then selected on
the basis of the strength of bivariate association to construct
a multivariable model. All statistically significant variables
seen on the bivariate model were chosen for the multivariable
model. Variables with significant bivariate associations were
studied further. Specifically, by using a t test, we looked at
the mean difference in the age of diagnosis vs dichotomized
density of the breast. Associations are presented as odds
ratios with 95% confidence intervals. All hypothesis tests
were performed by using a significance level of .05, and all
analyses were done with the R Statistical Package version
2.8.0 (2008; R Foundation, Vienna, Austria).ResultsBivariate AnalysisThe characteristics of the 285 cases are reported in Table 1.
Of the 285 study participants diagnosed with invasive breast
carcinoma, 109 had axillary lymph node metastasis (38%).
In the bivariate analysis, tumours that were node positive
were significantly associated with palpability (P ¼ .0003),
lymphovascular invasion (P ¼ .0001), histologic grade
(P ¼ .004), tumour size (P ¼ .0001), density of the breast on
mammography (P ¼ .02), and younger age at diagnosis
(P ¼ .0001).
Nodal status was not significantly associated with tumour
location in a 3-dimensional measurement with respect to the
posterior nipple line. In addition, other parameters used to
categorize tumour location 2-dimensionally by using quad-
rants or medial vs lateral regions of the breast were also not
significantly associated with nodal metastasis. Furthermore,
distance from the skin when using ultrasound measurement
was not significantly associated with positive nodal status.Multivariate AnalysisThe results of the logistic regression model are reported in
Table 2. In the multivariable model lymphovascular invasion
(P ¼ .001), younger age at diagnosis (P ¼ .01), and surgical
size (P ¼ .01) continued to be significantly associated with
axillary lymph node metastasis at the time of diagnosis.
Palpability of the tumour (P ¼ .07), histologic grade
(P ¼ .65), and density of the breast (P ¼ .91) were no longer
significantly associated with positive nodes.
Discussion
Axillary lymph node metastasis remains the most
predictive factor associated with prognosis for patients with
operable breast cancer [15]. In the last decade, numerous
studies tried to elucidate the association between breast
tumour location and axillary lymph node metastasis. The
research for the most part demonstrated that lymph node
metastasis occurs more commonly with tumours located in
the outer quadrants of the breast [1,6,9,14,16,17]. At the
same time, results of many studies found a worse prognosis
Table 1
Bivariate associations in 285 patients diagnosed with invasive breast carcinoma
N Variable Node negative (n ¼ 176) Node positive (n ¼ 109) OR 95% CI P value
285 Age of Dx (y)a
Mean (SD) 60.9 (11.6) 54.8 (12.9) 0.81 0.73e0.90 <.0001
238 OCP/HRT
No 121 (83%) 74 (80%) 1.00 d
Yes 25 (17%) 18 (20%) 1.18 0.60e2.30 .63
273 Palpability
No 73 (45%) 25 (23%) 1.00
Yes 91 (55%) 84 (77%) 2.70 1.57e4.64 .0003
263 Family Hx breast Ca
No 110 (69%) 77 (75%) 1.00
Yes 50 (31%) 26 (25%) 0.74 0.43e1.30 .29
269 Prior Hx breast Ca
No 147 (90%) 101 (95%) 1.00
Yes 16 (10%) 5 (5%) 0.45 0.16e1.28 .14
283 Density of breastb
BI-RADS 1 and 2 107 (61%) 51 (47%) 1.00
BI-RADS 3 and 4 68 (39%) 57 (53%) 1.74 1.07e2.82 .02
203 Distance from skin
1.0 cm 70 (58%) 45 (55%) 1.00
>1.0 cm 51 (42%) 37 (45%) 0.92 0.55e1.53 .75
285 Quadrant
UIQ 28 (16%) 12 (11%) 1.00
UOQ 94 (54%) 66 (61%) 1.64 0.78e3.45 .19
LOQ 16 (9%) 13 (12%) 1.90 0.70e5.14 .21
LIQ 27 (16%) 10 (9%) 0.86 0.32e2.33 .77
Periareolar 8 (5%) 8 (7%) 2.33 0.71e7.68 .16
285 Region
Periareolar 54 (31%) 23 (21%) 1.00
Medial 111 (63%) 78 (72%) 0.59 0.21e1.65 .31
Lateral 11 (6%) 8 (7%) 0.97 0.37e2.51 .94
285 a/pnlc
Mean (SD) 0.59 (0.20) 0.60 (0.23) 1.10 0.36e3.41 .87
285 c/pnlc
Mean (SD) 0.69 (0.26) 0.72 (0.30) 1.47 0.62e3.52 .38
281 ER þ tumour
No 52 (30%) 36 (34%) 1.00
Yes 122 (70%) 71 (66%) 0.84 0.50e1.41 .51
281 PR þ tumour
No 63 (36%) 43 (40%) 1.00
Yes 111 (64%) 64 (60%) 0.84 0.51e1.39 .50
278 Her2 þ tumour
No 151 (88%) 90 (84%) 1.00
Yes 20 (12%) 17 (16%) 1.43 0.71e2.86 .32
235 Calcifications
No 64 (44%) 39 (44%) 1.00
Yes 82 (56%) 50 (56%) 1.00 0.59e1.70 .99
259 Lymphovascular invasion
No 149 (92%) 71 (73%) 1.00
Yes 13 (8%) 26 (27%) 4.20 2.04e8.65 .0001
277 Histologic grade
1 and 2 120 (69%) 54 (52%) 1.00
3 53 (31%) 50 (48%) 2.10 1.27e3.46 .004
270 Surgical size (cm)
1.0 59 (34%) 9 (9%) 1.00
>1.0 113 (66%) 89 (91%) 5.16 2.43e10.98 <.0001
Boldface data denotes statistical significance (P < .05).
a ¼ as delineated on Figure 1; BI-RADS ¼ Breast Imaging Reporting and Data System; c ¼ as delineated on Figure 1; Ca ¼ cancer; CI ¼ confidence interval;
Dx ¼ diagnosis; ER = estrogen receptor positive; HRT ¼ hormone replacement therapy; Hx ¼ history; UIQ ¼ upper inner quadrant; UOQ ¼ upper outer
quadrant; LOQ ¼ lower outer quadrant; OR ¼ odds ratio; OCP ¼ oral contraceptive use; pnl ¼ posterior nipple line; PR ¼ progesterone receptor positive; SD,
standard deviation.
aOR for age expressed in terms of a 5-y increase.
bBI-RADS classification of density (1) fatty to (2) normal density vs (3) dense to (4) very dense.
cSee Figure 1.
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Table 2
Multiple logistic regression model of factors associated with axillary lymph
node metastasis
Variable OR 95% CI P value
Tumour palpable 1.07 0.42e2.71 .07
Lymphovascular invasion 6.49 2.10e20.08 .001
Age at diagnosisa 0.85 0.72e1.01 .01
Density >BI-RADS 2 0.86 0.37e2.01 .91
Histologic grade >2 1.61 0.69e3.77 .65
Surgical size >1.0 cm 1.70 0.58e4.97 .01
Boldface data denotes statistical significance (P < .05).
BI-RADS ¼ Breast Imaging Reporting and Data System; CI ¼ confidence
interval; OR ¼ odds ratio.
aOdds ratio for age expressed in terms of a 5-y increase.
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investigators purported that the association between outer
quadrant breast tumours and increased axillary metastasis
could be because the majority of breast tissue is found in the
outer breast. In addition, the poorer prognosis of medially
located tumours might be because metastatic spread to the
internal mammary lymph node chain is unaccounted for in
routine axillary lymph node dissection.
Recently, researchers attempted to characterize tumour
location association with axillary lymph node metastasis in
novel ways. Cunningham et al [20] characterized the risk of
axillary lymph node metastasis in terms of distance of the
tumour from the skin by using ultrasound. They found that
more superficial tumours were associated with axillary
metastasis at diagnosis and postulated that tumour proximity
to the lymphatic supply in the superficial dermal and
subdermal layers likely explained their finding [20]. Like-
wise, Guth et al [12] performed a case-control study that
compared axillary metastasis with tumours located in ante-
rior vs posterior locations in the breast, finding anterior
location of an invasive tumour that corresponded to a higher
chance of axillary metastasis at diagnosis. Guth et al [12]
proposed that anterior tumours in a 3-dimensional plane
had higher nodal metastasis because of the rich cutaneous
lymphatics of the superior, medial, and inferior breast that
drain laterally to the axilla.
Although some researchers found that tumour skin and
nipple involvement leads to higher rates of nodal metastasis,
no studies have focused solely on the relationship of tumour
location to the nipple [21]. Because of evidence that
demonstrates that major lymphatic trunks from breast
parenchyma connect directly with the subareolar plexus, we
set out to determine if tumour location in proximity to the
nipple had a higher rate of metastasis at diagnosis [13]. The
analysis of our study revealed no association between axil-
lary nodal metastasis at diagnosis and the 3-dimensional or
2-dimensional tumour location in relation to the nipple and
subareolar lymphatic plexus.
Our attempt to 3-dimensionally characterize tumour
proximity to the nipple failed to have any significant asso-
ciation most likely because of the inherent difficulty in
ascribing a ratio in relation to the posterior nipple line for
different breast sizes and shapes. Different techniques ofmammography examinations, such as degrees of breast
compression and tissue distribution, could have prevented
a standardization of measurement. Moreover, our 3-dimen-
sional assessment did not take into account the variability in
the lymphatic networks among patients, and it may be that
the exact location of the lymphatic network impacts whether
axillary metastasis exists at diagnosis. Perhaps future studies
that use lymphography can further assess the independent
prognostic value of tumour location in relation to the
lymphovascular network of the breast [22,23].
Moreover, our hypothesis that the convergence of
lymphatic networks at the nipple makes periareolar tumour
location a risk factor for axillary metastasis might be faulty.
Perhaps tumour characteristics, not tumour location,
portend breast cancer metastasis. At the same time, we did
find some evidence of a relationship between tumour
proximity to the nipple 2-dimensionally and axillary lymph
node metastasis (P ¼ .16), although insignificant. The
statistical insignificance of this relationship may be attrib-
utable to the small percentage of tumours found in the 2-
dimensional periareolar region from our study cohort (n ¼
16 [5%]). Further studies with a larger sample of women
with periareolar tumours might be needed to further assess
this relationship.
Our findings of no significant association between axillary
metastasis and tumour location contradict recent literature in
the last decade that postulates that tumour location can help
predict axillary metastasis. Even when using novel ways to
characterize tumour location by prescribing a 3-dimensional
view of the breast or by ultrasound distance from the skin,
we failed to find any significant association. Although not
significant, 2-dimensional medial tumour location (P ¼ .31)
was more likely to have axillary metastasis than lateral
2-dimensional medial location (P ¼ .94). This finding could
lend further evidence to the body of research that finds
medial tumour location associated with a worse prognosis and
higher rates of metastasis [11]. Our study does not corroborate
with studies in the literature that found outer quadrant tumours
have a greater chance of axillary metastasis [9].
Meanwhile, our data strongly support known tumour
variables associated with axillary metastasis at diagnosis,
such as surgical size, lymphovascular invasion, and younger
age of diagnosis [3e8,24]. Although our bivariate model
initially found palpability to be a significant variable asso-
ciated with axillary metastasis, it was no longer significant in
the multivariable model. On further examination, we found
that 88% of palpable tumours had a surgical size >1.0 cm
compared with just 55% of nonpalpable tumours with
a surgical size >1.0 cm. This finding suggests that palpa-
bility was really just playing a proxy or surrogate marker for
size of tumour. In addition, our bivariate model initially
found greater breast density on mammography (BI-RADS
categories 3 and 4) [14] to be associated with axillary nodal
metastasis (P ¼ .02); however, it appears that this finding was
confounded by age. On average, women with denser breasts
are 9.7 years younger than women with more fatty breasts
(P < .0001). The association between young age at diagnosis
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model, which suggests that, in fact, age, not breast density, is
the independent predictor for axillary metastasis at diagnosis.
In conclusion, we hope clinicians, when counseling
patients before surgery, will rely on known factors of axillary
metastasis, such as imaging size (to best approximate
surgical size), lymphovascular invasion, and younger age of
diagnosis, to guide discussions about prognosis. Further-
more, clinicians can advise patients with these known tumour
characteristics that they more likely will require a complete
axillary dissection because of a higher likelihood of posi-
tivity with sentinel lymph node biopsy. Because of our
results and the mixed data in the last 2 decades regarding
tumour location and its relationship to axillary metastasis,
tumour location does not appear to be a helpful predictor of
axillary metastasis at the time of diagnosis.References
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